Checchi Capital Advisers’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-1,480
Closed -$210K – 565
2021
Q3
$210K Buy
1,480
+87
+6% +$12.8K 0.02% 472
2021
Q2
$217K Buy
1,393
+80
+6% +$13K 0.02% 483
2021
Q1
$204K Sell
1,313
-140
-10% -$21.7K 0.02% 481
2020
Q4
$217K Sell
1,453
-238
-14% -$33.6K 0.02% 445
2020
Q3
$224K Buy
+1,691
New +$221K 0.02% 376
2020
Q1
– Sell
-1,803
Closed -$262K – 471
2019
Q4
$262K Sell
1,803
-4
-0.2% -$552 0.04% 336
2019
Q3
$241K Buy
1,807
+7
+0.4% +$904 0.03% 353
2019
Q2
$206K Buy
+1,800
New +$211K 0.03% 383
2018
Q4
– Sell
-2,070
Closed -$264K – 451
2018
Q3
$264K Buy
2,070
+26
+1% +$3.09K 0.03% 347
2018
Q2
$221K Sell
2,044
-17
-0.8% -$1.85K 0.03% 359
2018
Q1
$218K Buy
2,061
+88
+4% +$10.2K 0.03% 364
2017
Q4
$231K Buy
+1,973
New +$223K 0.03% 360
2017
Q2
– Sell
-1,838
Closed -$218K – 409
2017
Q1
$218K Buy
+1,838
New +$208K 0.03% 358
2016
Q4
– Sell
-1,774
Closed -$224K – 406
2016
Q3
$224K Sell
1,774
-113
-6% -$14K 0.03% 334
2016
Q2
$221K Buy
1,887
+68
+4% +$7.7K 0.03% 317
2016
Q1
$188K Sell
1,819
-470
-21% -$45.5K 0.04% 363
2015
Q4
$228K Sell
2,289
-167
-7% -$16.3K 0.06% 295
2015
Q3
$224K Buy
2,456
+298
+14% +$29.9K 0.06% 296
2015
Q2
$229K Buy
2,158
+133
+7% +$14.7K 0.06% 306
2015
Q1
$231K Buy
+2,025
New +$231K 0.07% 292

Other funds holding ZBH

Checchi Capital Advisers's ZBH Position: Q4 2021 in Review

Checchi Capital Advisers sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 1,480 shares — an estimated $210K sold.

Checchi Capital Advisers first reported a position in ZBH in Q1 2015 and held it in 20 quarters. The position peaked at $264K in Q3 2018. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • Checchi Capital Advisers reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • Checchi Capital Advisers sold 1,480 Zimmer Biomet shares in Q4 2021, an estimated $210K.
  • Checchi Capital Advisers first reported a position in Zimmer Biomet in Q1 2015 and held it in 20 quarters.
  • Checchi Capital Advisers's Zimmer Biomet position peaked at $264K in Q3 2018.
  • 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Checchi Capital Advisers's 13F filing for Q4 2021, filed 9 Feb 2022.